Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Abroad (travel likely)RecruitingPHASE1

Conditions

Atopic Dermatitis (AD) · Eczema

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Clinical Site 101, Fair Lawn, New Jersey, United States
Clinical · medinfo@arcutis.com · 1-844-692-6729

Study leads

David Berk, MD
Study Director
Arcutis Biotherapeutics

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

Atopic Dermatitis · Atopic Dermatitis Eczema · Eczema

Abroad (travel likely)RecruitingPHASE2

South San Francisco, United States

Herbal Ointment in Treating Atopic Dermatitis Topically

Atopic Dermatitis · Atopic Dermatitis (AD) · Atopic Dermatitis (Eczema)

Abroad (travel likely)RecruitingPHASE2, PHASE3

New Taipei City, Taiwan

A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

Atopic Dermatitis · Eczema

Abroad (travel likely)Recruiting

Amiens, France · Besançon, France

Global Healthcare Study on Atopic Dermatitis

Atopic Dermatitis (AD) · Atopic Dermatitis (Eczema)

Abroad (travel likely)Recruiting

Zurich, Switzerland